Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.
Anthem (ANTM) Q1 Earnings Beat Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 2.19% and -3.42%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth (UNH) to Help Eligible Medicaid Members in Ohio
by Zacks Equity Research
UnitedHealth (UNH) intends to improve health outcomes of eligible Medicaid members in Ohio where it already boasts a strong presence.
Why Anthem (ANTM) Might Surprise This Earnings Season
by Zacks Equity Research
Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Anthem (ANTM) to Report Q1 Earnings: What's in its Store?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings to reflect better revenues and higher membership.
UnitedHealth (UNH) Beats on Q1 Earnings, Revises '21 Guidance
by Zacks Equity Research
UnitedHealth's (UNH) first-quarter 2021 earnings grow on the back of increased revenues.
Anthem (ANTM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
UnitedHealth's (UNH) first-quarter results are likely to reflect well-performing UnitedHealthcare and Optum businesses, partly offset by elevated expenses related to COVID-19 pandemic.
Cigna (CI), Oscar to Aid Small Business With Health Insurance
by Zacks Equity Research
Cigna (CI) along with Oscar Health rolls out a health insurance product aimed for small business units in the state of California.
UnitedHealth (UNH) to Aid Eligible Medicaid Members in Hawaii
by Zacks Equity Research
UnitedHealth (UNH) to improve health outcomes of Medicaid members in Hawaii through contract wins.
Here's Why You Should Stay Away From Anthem (ANTM) Right Now
by Zacks Equity Research
Anthem's (ANTM) weak balance sheet and steep expenses will likely keep the stock stressed.
Here's Why Hold Strategy is Apt for Centene (CNC) Stock
by Zacks Equity Research
Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.
Top Stock Reports for UnitedHealth, Sony & American Tower
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), Sony (SNE), and American Tower (AMT).
Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business
by Zacks Equity Research
Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.
UnitedHealthcare (UNH) Expands Virtual Care to Hearing Aids
by Zacks Equity Research
UnitedHealthcare's (UNH) new virtual care model Right2You aims to provide its members with an online service for custom-programed hearing aids.
Centene (CNC) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Centene (CNC) and Humana (HUM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable based on fundamentals.
UnitedHealth (UNH) Invests in Technology to Lead the Industry
by Zacks Equity Research
The breakout of COVID-19 fuels the use of technology in the healthcare space and UnitedHealth (UNH) is promptly acting on this to ramp up its technological innovations.
Anthem (ANTM) Down 0.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Workday (WDAY) Q4 Earnings Surpass Estimates, Stock Down
by Zacks Equity Research
Workday's (WDAY) fiscal fourth-quarter results benefit from a high demand for its cloud-based HCM and FINS plus solutions, and synergies from the Scout RFP acquisition.
Centene's (CNC) Hawaii Arm to Keep Offering Healthcare Services
by Zacks Equity Research
Centene's (CNC) Hawaii subsidiary 'Ohana Health Plan is selected to continue catering services via the CSS plan.
Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.
Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Centene (CNC) Q4 results gain from improved revenues as well as better membership.
Cigna (CI) Q4 Earnings Miss, Decline Y/Y on Elevated Claims
by Zacks Equity Research
Cigna's (CI) Q4 results reflect higher revenues, partly offset by an increase in COVID-related claims that eroded its bottom line.
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.
Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.